Netoglitazone

Rabbit anti Human QKI Antibody, Recombinant (R01-3F7), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Function:RNA-binding protein that plays a central role in myelinization (PubMed:16641098). Binds to the

Rabbit anti Human QKI Antibody, Recombinant (R01-3F7), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Function:RNA-binding protein that plays a central role in myelinization (PubMed:16641098). Binds to the

Rabbit anti Human QKI Antibody, Recombinant (R01-3F7), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Function:RNA-binding protein that plays a central role in myelinization (PubMed:16641098). Binds to the

Rabbit anti Human Rap1A/Rap1B Antibody, Recombinant (R03-7H8), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Relevance:RAP1A: Induces morphological reversion of a cell line transformed by a Ras oncogene. Counteracts the

Rabbit anti Human Rap1A/Rap1B Antibody, Recombinant (R03-7H8), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Relevance:RAP1A: Induces morphological reversion of a cell line transformed by a Ras oncogene. Counteracts the

Rabbit anti Human Rap1A/Rap1B Antibody, Recombinant (R03-7H8), could be used for WB and so on.Application:WB: 1/500-1/1000 Protein Relevance:RAP1A: Induces morphological reversion of a cell line transformed by a Ras oncogene. Counteracts the

Rabbit anti Human Sonic Hedgehog Antibody, Recombinant, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/2000IHC: 1/50-1/200Protein FunctionBinds to the patched (PTC) receptor, which functions in association with smoothened (SMO), to

Rabbit anti Human Sonic Hedgehog Antibody, Recombinant, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/2000IHC: 1/50-1/200Protein FunctionBinds to the patched (PTC) receptor, which functions in association with smoothened (SMO), to

InformationRo 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist. Ro 46-2005 inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.

InformationRo 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist. Ro 46-2005 inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.

InformationRo 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist. Ro 46-2005 inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.

InformationRo 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist. Ro 46-2005 inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.